Q32 Bio Prices $200 Million Equity Raise
Clinical-stage biotechnology company Q32 Bio has priced a public offering expected to raise approximately $200 million in gross proceeds. The firm is issuing 6.03 million shares of common stock at $18.25 per share, with pre-funded warrants offered for certain investors.
Tickers: $QTTB